Skip to content
Fiscal Receipts

Senate LDA lobbying filing

HUMANA INC

Registrant: HUMANA, INC. Year: 2025 Period: Second Quarter Type: Q2

View on lda.senate.gov ↗

Reported income

not reported

Reported expenses

$730.0K

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

  • SPQ-9B Radar2026matched: “2026PE code cited directly

    Medicare Advantage (MA) Policy and Reimbursement Enactment of policies in Calendar Year (CY) 2024 Medicare Advantage…

Lobbying activities4

  • DefenseDEF

    TRICARE Policy Issues including Telehealth, Value-Based Care, and T-5 Transition NDAA Implementation Policy Issues Veterans Healthcare and Policy Issues PL 118-159, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025

  • Medicare/MedicaidMMM

    Medicare Advantage (MA) Policy and Reimbursement Enactment of policies in Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Medicare Part D Issues Medicaid Policy Issues Including Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 H.R. 3514/S.1816, Improving Seniors Timely Access to Care Act (119th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health Calendar Year (CY) 2024 Home Health Prospective Payment System Final Rule (CMS-1780-F) Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final Rule (CMS 1793-F) Implementation of CMS Interoperability and Prior Authorization final rule (CMS-0057-F) Calendar Year (CY) 2025 Home Health Prospective Payment System Final Rule (CMS-1803-F) Contract Year 2025 Medicare Advantage and Part D Final Rule (CMS-4205-F) Announcement of Calendar Year (CY) 2025 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Final Calendar Year (CY) 2025 Part D Redesign Program Instructions Fiscal Year (FY) 2025 Hospice Payment Rate Update Final Rule (CMS-1810-F) PL 119-21, One Big Beautiful Bill Act S.1105, No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act H.R. 3467, Medicare Advantage Reform Act Policy issues related to VA-eligible Medicare beneficiaries Calendar Year (CY) 2026 Home Health Prospective Payment System Proposed Rule (CMS-1828-P) Fiscal Year 2026 Skilled Nursing Facility Prospective Payment System Proposed Rule (CMS 1827-P) Fiscal Year 2026 Hospice Wage Index and Payment Rate Update Proposed Rule (CMS-1835-P) FY 2026 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Proposed Rule (CMS-1833-P) Final Calendar Year (CY) 2026 Part D Redesign Program Instructions Draft Guidance for the Third Cycle of Medicare Drug Price Negotiation Program Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-F) Announcement of Calendar Year (CY) 2026 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (CY 2026 Rate Announcement)

  • PharmacyPHA

    Prescription drug pricing Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues

  • Taxation/Internal Revenue CodeTAX

    Tax Reform Implementation Issues PL 119-21, One Big Beautiful Bill Act

Lobbyists4

  • JEFFREY LUNGREN
  • KAITLYN LANE
  • RACHEL MAGNUSON
  • TIFFANY HAVERLY

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.